Rankings
▼
Calendar
ALT Q4 2015 Earnings — Altimmune, Inc. Revenue & Financial Results | Market Cap Arena
ALT
Altimmune, Inc.
$331M
Q4 2015 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$1M
Gross Profit
-$277,667
-21.9% margin
Operating Income
-$940,469
-74.3% margin
Net Income
-$1M
-97.8% margin
EPS (Diluted)
$-5.77
Cash Flow
Operating Cash Flow
-$2M
Free Cash Flow
-$2M
Stock-Based Comp.
$186,029
Balance Sheet
Total Assets
$20M
Total Liabilities
$3M
Stockholders' Equity
$17M
Cash & Equivalents
$16M
← FY 2015
All Quarters
Q1 2016 →